ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Vysali Pharmaceuticals

Vysali Pharmaceuticals, an existing dividend paying company manufacturing a wide range of pharmaceutical formula-tions, is setting up a bulk drugs plant for the manufacture of semi synthetic peni-cillins, antibiotics and antibacterial in a phased manner, expecting to earn a reasonable profit working at 10 per cent, 30 per cent and 45 per cent of installed capacity in the first, second and third year of operations. The implementation of the first phase will be completed by September 1992 and the entire project by September 1993,

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Back to Top